Long-acting injectable ART: next revolution in HIV?

被引：13

作者：

Boyd, Mark A. ^{[1
,2
]}

Cooper, David A. ^{[2
]}

机构：

[1] Univ Adelaide, Lyell McEwin Hosp, Elizabeth Vale, SA 5112, Australia

[2] Univ New South Wales, Kirby Inst, Sydney, NSW 2052, Australia

来源：

LANCET | 2017年 / 390卷 / 10101期

关键词：

REVERSE-TRANSCRIPTASE INHIBITORS; INFECTED PATIENTS; NAIVE ADULTS; DOUBLE-BLIND; TRIAL; THERAPY;

D O I：

10.1016/S0140-6736(17)31962-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1468 / 1470

页数：4

共 50 条

[1] Long-acting injectable HIV therapies: the next frontier
Thornhill, John
Orkin, Chloe
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (01) : 8 - 15
[2] Long-acting injectable HIV therapies: the next frontier: Republication
Thornhill, John
Orkin, Chloe
[J]. CURRENT OPINION IN HIV AND AIDS, 2021, 16 (02) : 98 - 105
[3] Long-acting injectable ART for HIV: a (cautious) step forward
Venkatesan, Priya
[J]. LANCET MICROBE, 2022, 3 (02): : E94 - E94
[4] Long-acting injectable for HIV approved for use in the UK
Kirby, Tony
[J]. LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 26 - 26
[5] Long-acting injectable cabotegravir for the prevention of HIV infection
Clement, Meredith E.
Kofron, Ryan
Landovitz, Raphael J.
[J]. CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 19 - 26
[6] Long-acting injectable antiretrovirals for HIV treatment and prevention
Spreen, William R.
Margolis, David A.
Pottage, John C., Jr.
[J]. CURRENT OPINION IN HIV AND AIDS, 2013, 8 (06) : 565 - 571
[7] Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
Kim, Yeon-Sook
[J]. INFECTION AND CHEMOTHERAPY, 2021, 53 (04): : 686 - 695
[8] Cabotegravir: The First Long-Acting Injectable for HIV Preexposure Prophylaxis
Durham, Spencer H.
Milam, Ashlee
Waer, Dylan
Chahine, Elias B.
[J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (03) : 306 - 316
[9] LONG-ACTING INJECTABLE CONTRACEPTIVES
VECCHIO, TJ
[J]. ADVANCES IN STEROID BIOCHEMISTRY AND PHARMACOLOGY, 1976, 5 : 1 - 64
[10] Long-acting injectable risperidone
Ehret, MJ
Fuller, MA
[J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2122 - 2127

← 1 2 3 4 5 →